BAKER BROS. ADVISORS LP 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:13 pm Sale | 2025-12-31 | 13G | STOKE THERAPEUTICS INC STOK | BAKER BROS. ADVISORS LP | 3,336,697 5.800% | -1,031,746 (-23.62%) | Filing |
| 2024-11-14 4:24 pm Purchase | 2024-09-30 | 13G | STOKE THERAPEUTICS INC STOK | BAKER BROS. ADVISORS LP | 4,368,443 8.300% | 4,368,443 (New Position) | Filing |